SEARCH

SEARCH BY CITATION

References

  • 1
    The UniProt Consortium (2012) Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 40, D7175.
  • 2
    Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR et al. (2011) CDD: a conserved domain database for the functional annotation of proteins. Nucleic Acids Res 39, D225229.
  • 3
    Porter CT, Bartlett GJ & Thornton JM (2004) The Catalytic Site Atlas: a resource of catalytic sites and residues identified in enzymes using structural data. Nucleic Acids Res 32, D129133.
  • 4
    Holliday GL, Andreini C, Fischer JD, Rahman SA, Almonacid DE, Williams ST & Pearson WR (2012) MACiE: exploring the diversity of biochemical reactions. Nucleic Acids Res 40, D783789.
  • 5
    Laskowski RA (2009) PDBsum new things. Nucleic Acids Res 37, D355359.
  • 6
    Wallace AC, Laskowski RA & Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8, 127134.
  • 7
    Hartmann T, Terao M, Garattini E, Teutloff C, Alfaro JF, Jones JP & Leimkuhler S (2012) The impact of single nucleotide polymorphisms on human aldehyde oxidase. Drug Metab Dispos 40, 856864.
  • 8
    Li CY, Yu Q, Ye ZQ, Sun Y, He Q, Li XM, Zhang W, Luo J, Gu X, Zheng X et al. (2007) A nonsynonymous SNP in human cytosolic sialidase in a small Asian population results in reduced enzyme activity: potential link with severe adverse reactions to oseltamivir. Cell Res 17, 357362.
  • 9
    Aleem AM, Wells L, Jankun J, Walther M, Kuhn H, Reinartz J & Skrzypczak-Jankun E (2009) Human platelet 12–lipoxygenase: naturally occurring Q261/R261 variants and N544L mutant show altered activity but unaffected substrate binding and membrane association behavior. Int J Mol Med 24, 759764.
  • 10
    Lee YJ, Horie Y, Wallace GR, Choi YS, Park JA, Song R, Kang YM, Kang SW, Baek HJ, Kitaichi N et al. (2012) Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease. Ann Rheum Dis, doi:10.1136/annrheumdis-2011-200288.
  • 11
    Renz KG, Cheetham BF & Walkden-Brown SW (2012) Differentiation between pathogenic serotype 1 isolates of Marek's disease virus and the Rispens CVI988 vaccine in Australia using real-time PCR and high resolution melt curve analysis. J Virol Methods 187, 144152.
  • 12
    Antonopoulos AS, Tousoulis D, Antoniades C, Miliou A, Hatzis G, Papageorgiou N, Demosthenous M, Tentolouris C & Stefanadis C (2012) Genetic variability on adiponectin gene affects myocardial infarction risk: the role of endothelial dysfunction. Int J Cardiol, doi:10.1016/j.ijcard.2012.09.053.
  • 13
    Nemoto H, Tate G, Kishimoto K, Saito M, Shirahata A, Umemoto T, Matsubara T, Goto T, Mizukami H, Kigawa G et al. (2012) Heterozygous loss of NF2 is an early molecular alteration in well-differentiated papillary mesothelioma of the peritoneum. Cancer Genet 205, 594598.
  • 14
    Zeng BJ, Wang ZH, Ribeiro LA, Leone P, De Gasperi R, Kim SJ, Raghavan S, Ong E, Pastores GM & Kolodny EH (2002) Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease. J Inherit Metab Dis 25, 557570.
  • 15
    Zankl A, Bonafe L, Calcaterra V, Di Rocco M & Superti-Furga A (2005) Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2. Clin Genet 67, 261266.
  • 16
    Riballo E, Doherty AJ, Dai Y, Stiff T, Oettinger MA, Jeggo PA & Kysela B (2001) Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity. J Biol Chem 276, 3112431132.
  • 17
    Allali-Hassani A, Wasney GA, Chau I, Hong BS, Senisterra G, Loppnau P, Shi Z, Moult J, Edwards AM, Arrowsmith CH et al. (2009) A survey of proteins encoded by non-synonymous single nucleotide polymorphisms reveals a significant fraction with altered stability and activity. Biochem J 424, 1526.
  • 18
    Schaefer C & Rost B (2012) Predict impact of single amino acid change upon protein structure. BMC Genomics 13 (Suppl 4), S4.
  • 19
    Shakhnovich EI & Gutin AM (1991) Influence of point mutations on protein structure: probability of a neutral mutation. J Theor Biol 149, 537546.
  • 20
    Gong S & Blundell TL (2010) Structural and functional restraints on the occurrence of single amino acid variations in human proteins. PLoS One 5, e9186.
  • 21
    Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM & Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29, 308311.
  • 22
    Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A et al. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39, D945950.
  • 23
    Karagiannis K, Simonyan V & Mazumder R (2012) SNVDis: a proteome-wide analysis service for evaluating nsSNVs in active sites, binding sites, pathways and protein domains. Genomics Proteomics Bioinformatics, doi:10.1016/j.gpb.2012.10.003.
  • 24
    Mazumder R, Morampudi KS, Motwani M, Vasudevan S & Goldman R (2012) Proteome-wide analysis of single-nucleotide variations in the N–glycosylation sequon of human genes. PLoS One 7, e36212.
  • 25
    Ng PC, Levy S, Huang J, Stockwell TB, Walenz BP, Li K, Axelrod N, Busam DA, Strausberg RL & Venter JC (2008) Genetic variation in an individual human exome. PLoS Genet 4, e1000160.
  • 26
    Cook BW & Shaw GS (2012) Architecture of the catalytic HPN motif is conserved in all E2 conjugating enzymes. Biochem J 445, 167174.
  • 27
    Mili A, Ben Charfeddine I, Mamai O, Abdelhak S, Adala L, Amara A, Pagliarani S, Lucchiarri S, Ayadi A, Tebib N et al. (2012) Molecular and biochemical characterization of Tunisian patients with glycogen storage disease type III. J Hum Genet 57, 170175.
  • 28
    Amarinthnukrowh P, Tongkobpetch S, Kongpatanayothin A, Suphapeetiporn K & Shotelersuk V (2010) p.D645E of acid alpha-glucosidase is the most common mutation in thai patients with infantile-onset pompe disease. Genet Test Mol Biomarkers 14, 835837.
  • 29
    Xu S, Qin S, Gu X, Qiu W, Ye J, Han L & He L (2010) Rapid detection of glycogen storage disease type Ia by DNA microarray. Clin Chem Lab Med 48, 12291234.
  • 30
    Christensen BC, Smith AA, Zheng S, Koestler DC, Houseman EA, Marsit CJ, Wiemels JL, Nelson HH, Karagas MR, Wrensch MR et al. (2011) DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J Natl Cancer Inst 103, 143153.
  • 31
    Li J, Humphreys K, Darabi H, Rosin G, Hannelius U, Heikkinen T, Aittomaki K, Blomqvist C, Pharoah PD, Dunning AM et al. (2010) A genome-wide association scan on estrogen receptor-negative breast cancer. Breast Cancer Res 12, R93.
  • 32
    Li BQ, Huang T, Liu L, Cai YD & Chou KC (2012) Identification of colorectal cancer related genes with mRMR and shortest path in protein–protein interaction network. PLoS One 7, e33393.
  • 33
    Iyer L, Das S, Janisch L, Wen M, Ramirez J, Karrison T, Fleming GF, Vokes EE, Schilsky RL & Ratain MJ (2002) UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Pharmacogenomics J 2, 4347.
  • 34
    Yue Z, Song Y, Wang Z, Luo Y, Jiang L, Xing L, Xu H & Zhang X (2010) Association of heparanase gene (HPSE–1) single nucleotide polymorphisms with gastric cancer. J Surg Oncol 102, 6872.
  • 35
    Hickey DA, Benkel BF & Magoulas C (1989) Molecular biology of enzyme adaptations in higher eukaryotes. Genome 31, 272283.
  • 36
    Wolford JK, Yeatts KA, Red Eagle AR, Nelson RG, Knowler WC & Hanson RL (2006) Variants in the gene encoding aldose reductase (AKR1B1) and diabetic nephropathy in American Indians. Diabet Med 23, 367376.
  • 37
    Makiishi T, Araki S, Koya D, Maeda S, Kashiwagi A & Haneda M (2003) C–106T polymorphism of AKR1B1 is associated with diabetic nephropathy and erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes mellitus. Am J Kidney Dis 42, 943951.
  • 38
    Sapru A, Wiemels JL, Witte JS, Ware LB & Matthay MA (2006) Acute lung injury and the coagulation pathway: potential role of gene polymorphisms in the protein C and fibrinolytic pathways. Intensive Care Med 32, 12931303.
  • 39
    Yuan ZM, Huang Y, Ishiko T, Kharbanda S, Weichselbaum R & Kufe D (1997) Regulation of DNA damage-induced apoptosis by the c–Abl tyrosine kinase. Proc Natl Acad Sci USA 94, 14371440.
  • 40
    Perkinton MS, Standen CL, Lau KF, Kesavapany S, Byers HL, Ward M, McLoughlin DM & Miller CC (2004) The c–Abl tyrosine kinase phosphorylates the Fe65 adaptor protein to stimulate Fe65/amyloid precursor protein nuclear signaling. J Biol Chem 279, 2208422091.
  • 41
    Koh H, Lee KH, Kim D, Kim S, Kim JW & Chung J (2000) Inhibition of Akt and its anti-apoptotic activities by tumor necrosis factor-induced protein kinase C-related kinase 2 (PRK2) cleavage. J Biol Chem 275, 3445134458.
  • 42
    Landgraf KE, Pilling C & Falke JJ (2008) Molecular mechanism of an oncogenic mutation that alters membrane targeting: Glu17Lys modifies the PIP lipid specificity of the AKT1 PH domain. Biochemistry 47, 1226012269.
  • 43
    Jones DT, Kocialkowski S, Liu L, Pearson DM, Backlund LM, Ichimura K & Collins VP (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68, 86738677.
  • 44
    Dietrich G, Algiman M, Sultan Y, Nydegger UE & Kazatchkine MD (1992) Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg). Blood 79, 29462951.
  • 45
    Delfino FJ, Stevenson H & Smithgall TE (2006) A growth-suppressive function for the c–fes protein-tyrosine kinase in colorectal cancer. J Biol Chem 281, 88298835.
  • 46
    Kanda S, Miyata Y, Kanetake H & Smithgall TE (2009) Downregulation of the c–Fes protein-tyrosine kinase inhibits the proliferation of human renal carcinoma cells. Int J Oncol 34, 8996.
  • 47
    Miyata Y, Watanabe S, Matsuo T, Hayashi T, Sakai H, Xuan JW, Greer PA & Kanda S (2012) Pathological significance and predictive value for biochemical recurrence of c–Fes expression in prostate cancer. Prostate 72, 201208.
  • 48
    Borowiec M, Liew CW, Thompson R, Boonyasrisawat W, Hu J, Mlynarski WM, El Khattabi I, Kim SH, Marselli L, Rich SS et al. (2009) Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction. Proc Natl Acad Sci USA 106, 1446014465.
  • 49
    Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L & Henry RR (2000) Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 49, 263271.
  • 50
    Davis LM, McGraw RA, Ware JL, Roberts HR & Stafford DW (1987) Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B. Blood 69, 140143.
  • 51
    Ichinose A, Espling ES, Takamatsu J, Saito H, Shinmyozu K, Maruyama I, Petersen TE & Davie EW (1991) Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. Proc Natl Acad Sci USA 88, 115119.
  • 52
    Aono S, Adachi Y, Uyama E, Yamada Y, Keino H, Nanno T, Koiwai O & Sato H (1995) Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet 345, 958959.
  • 53
    Sneitz N, Bakker CT, de Knegt RJ, Halley DJ, Finel M & Bosma PJ (2010) Crigler–Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype–phenotype correlation, and functional analysis of 10 missense mutants. Hum Mutat 31, 5259.
  • 54
    Moghrabi N, Clarke DJ, Boxer M & Burchell B (1993) Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler–Najjar syndrome type 2. Genomics 18, 171173.
  • 55
    Salzmann A, Guipponi M, Lyons PJ, Fricker LD, Sapio M, Lambercy C, Buresi C, Ouled Amar Bencheikh B, Lahjouji F, Ouazzani R et al. (2012) Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial form of febrile seizures and temporal lobe epilepsy and in sporadic temporal lobe epilepsy. Hum Mutat 33, 124135.
  • 56
    Fluck CE, Meyer-Boni M, Pandey AV, Kempna P, Miller WL, Schoenle EJ & Biason-Lauber A (2011) Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation. Am J Hum Genet 89, 201218.
  • 57
    Roberts LD, Souza AL, Gerszten RE & Clish CB (2012) Targeted metabolomics. Curr Protoc Mol Biol (Ausubel FM, ed.), Chapter 30, Unit 30 2 124, doi:10.1002/0471142727.mb3002s98.
  • 58
    Bolton E, Wang Y, Thiessen PA & Bryant SH (2008) PubChem: integrated platform of small molecules and biological activities. Annual Reports in Computational Chemistry, Chapter 12. American Chemical Society, Washington, DC.
  • 59
    Pind S, Slominski E, Mauthe J, Pearlman K, Swoboda KJ, Wilkins JA, Sauder P & Natowicz MR (2002) V490M, a common mutation in 3–phosphoglycerate dehydrogenase deficiency, causes enzyme deficiency by decreasing the yield of mature enzyme. J Biol Chem 277, 71367143.
  • 60
    Klomp LW, de Koning TJ, Malingre HE, van Beurden EA, Brink M, Opdam FL, Duran M, Jaeken J, Pineda M, Van Maldergem L et al. (2000) Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency – a neurometabolic disorder associated with reduced l–serine biosynthesis. Am J Hum Genet 67, 13891399.
  • 61
    Jaffe EK, Martins J, Li J, Kervinen J & Dunbrack RL Jr (2001) The molecular mechanism of lead inhibition of human porphobilinogen synthase. J Biol Chem 276, 15311537.
  • 62
    Jaffe EK & Stith L (2007) ALAD porphyria is a conformational disease. Am J Hum Genet 80, 329337.
  • 63
    Ishida N, Fujita H, Fukuda Y, Noguchi T, Doss M, Kappas A & Sassa S (1992) Cloning and expression of the defective genes from a patient with delta-aminolevulinate dehydratase porphyria. J Clin Invest 89, 14311437.
  • 64
    Plewinska M, Thunell S, Holmberg L, Wetmur JG & Desnick RJ (1991) delta-Aminolevulinate dehydratase deficient porphyria: identification of the molecular lesions in a severely affected homozygote. Am J Hum Genet 49, 167174.
  • 65
    Homuth G, Teumer A, Volker U & Nauck M (2012) A description of large-scale metabolomics studies: increasing value by combining metabolomics with genome-wide SNP genotyping and transcriptional profiling. J Endocrinol 215, 1728.
  • 66
    Chan ET, Quon GT, Chua G, Babak T, Trochesset M, Zirngibl RA, Aubin J, Ratcliffe MJ, Wilde A, Brudno M et al. (2009) Conservation of core gene expression in vertebrate tissues. J Biol 8, 33.
  • 67
    Liu F, Yuan D, Wei Y, Wang W, Yan L, Wen T, Xu M, Yang J & Li B (2012) Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk. PLoS One 7, e43821.
  • 68
    Sherva R, Ford CE, Eckfeldt JH, Davis BR, Boerwinkle E & Arnett DK (2011) Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study. Stroke 42, 330335.
  • 69
    Binns D, Dimmer E, Huntley R, Barrell D, O'Donovan C & Apweiler R (2009) QuickGO: a web-based tool for Gene Ontology searching. Bioinformatics 25, 30453046.
  • 70
    Boc-Zalewska A, Seremak-Mrozikiewicz A, Barlik M, Kurzawinska G & Drews K (2012) Contribution of maternal–fetal adrenomedullin polymorphism to gestational hypertension and preedlampsia – gene–gene interaction pilot study. Ginekol Pol 83, 494500.
  • 71
    Yin Y, Li F & Wang DM (2012) Association between estrogen receptor beta gene polymorphisms in Chinese Uygur patients and intrahepatic cholestasis of pregnancy. Chin J Med Genet 29, 319322.
  • 72
    van der Burg M, van Veelen LR, Verkaik NS, Wiegant WW, Hartwig NG, Barendregt BH, Brugmans L, Raams A, Jaspers NG, Zdzienicka MZ et al. (2006) A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. J Clin Invest 116, 137145.
  • 73
    Messika-Zeitoun L, Gouedard L, Belville C, Dutertre M, Lins L, Imbeaud S, Hughes IA, Picard JY, Josso N & di Clemente N (2001) Autosomal recessive segregation of a truncating mutation of anti-Mullerian type II receptor in a family affected by the persistent Mullerian duct syndrome contrasts with its dominant negative activity in vitro. J Clin Endocrinol Metab 86, 43904397.
  • 74
    Bacci S, Ludovico O, Prudente S, Zhang YY, Di Paola R, Mangiacotti D, Rauseo A, Nolan D, Duffy J, Fini G et al. (2005) The K121Q polymorphism of the ENPP1/PC–1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction. Diabetes 54, 30213025.
  • 75
    Demirhan O, Turkmen S, Schwabe GC, Soyupak S, Akgul E, Tastemir D, Karahan D, Mundlos S & Lehmann K (2005) A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies. J Med Genet 42, 314317.
  • 76
    Boucher J, Quilliot D, Praderes JP, Simon MF, Gres S, Guigne C, Prevot D, Ferry G, Boutin JA, Carpene C et al. (2005) Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression. Diabetologia 48, 569577.
  • 77
    Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S et al. (2006) Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355, 788798.
  • 78
    Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudaut C et al. (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81, 2740.
  • 79
    Morgunova E, Tuuttila A, Bergmann U, Isupov M, Lindqvist Y, Schneider G & Tryggvason K (1999) Structure of human pro-matrix metalloproteinase–2: activation mechanism revealed. Science 284, 16671670.
  • 80
    Martignetti JA, Aqeel AA, Sewairi WA, Boumah CE, Kambouris M, Mayouf SA, Sheth KV, Eid WA, Dowling O, Harris J et al. (2001) Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 28, 261265.
  • 81
    Davis AP, Wiegers TC, Rosenstein MC & Mattingly CJ (2012) MEDIC: a practical disease vocabulary used at the Comparative Toxicogenomics Database. Database 2012, bar065.
  • 82
    Schriml LM, Arze C, Nadendla S, Chang YW, Mazaitis M, Felix V, Feng G & Kibbe WA (2012) Disease ontology: a backbone for disease semantic integration. Nucleic Acids Res 40, D940946.
  • 83
    Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446, 153158.
  • 84
    Kishi H, Mukai T, Hirono A, Fujii H, Miwa S & Hori K (1987) Human aldolase A deficiency associated with a hemolytic anemia: thermolabile aldolase due to a single base mutation. Proc Natl Acad Sci USA 84, 86238627.
  • 85
    Lee WJ, Lee HM, Chi CS, Shu SG, Lin LY & Lin WH (1996) Genetic analysis of the glucose-6-phosphatase mutation of type 1a glycogen storage disease in a Chinese family. Clin Genet 50, 206211.
  • 86
    Tsujino S, Servidei S, Tonin P, Shanske S, Azan G & DiMauro S (1994) Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency. Am J Hum Genet 54, 812819.
  • 87
    Maekawa M, Sudo K, Kanno T & Li SS (1990) Molecular characterization of genetic mutation in human lactate dehydrogenase-A(M) deficiency. Biochem Biophys Res Commun 168, 677682.
  • 88
    Hermans MM, de Graaff E, Kroos MA, Wisselaar HA, Oostra BA & Reuser AJ (1991) Identification of a point mutation in the human lysosomal alpha-glucosidase gene causing infantile glycogenosis type II. Biochem Biophys Res Commun 179, 919926.
  • 89
    Sallai A, Solyom J, Dobos M, Szabo J, Halasz Z, Sagodi L, Niederland T, Kozari A, Bertalan R, Ugocsai P et al. (2010) Y-chromosome markers in Turner syndrome: screening of 130 patients. J Endocrinol Invest 33, 222227.
  • 90
    van Beurden EA, de Graaf M, Wendel U, Gitzelmann R, Berger R & van den Berg IE (1997) Autosomal recessive liver phosphorylase kinase deficiency caused by a novel splice-site mutation in the gene encoding the liver gamma subunit (PHKG2). Biochem Biophys Res Commun 236, 544548.
  • 91
    Burwinkel B, Bakker HD, Herschkovitz E, Moses SW, Shin YS & Kilimann MW (1998) Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. Am J Hum Genet 62, 785791.
  • 92
    Milunsky JM, Zhao G, Maher TA, Colby R & Everman DB (2006) LADD syndrome is caused by FGF10 mutations. Clin Genet 69, 349354.
  • 93
    Rohmann E, Brunner HG, Kayserili H, Uyguner O, Nurnberg G, Lew ED, Dobbie A, Eswarakumar VP, Uzumcu A, Ulubil-Emeroglu M et al. (2006) Mutations in different components of FGF signaling in LADD syndrome. Nat Genet 38, 414417.
  • 94
    Benzinou M, Creemers JW, Choquet H, Lobbens S, Dina C, Durand E, Guerardel A, Boutin P, Jouret B, Heude B et al. (2008) Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet 40, 943945.
  • 95
    Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A, Bergholm R, Arkkila P, Arola J, Kiviluoto T et al. (2009) A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 52, 10561060.
  • 96
    Dianzani I, de Sanctis L, Smooker PM, Gough TJ, Alliaudi C, Brusco A, Spada M, Blau N, Dobos M, Zhang HP et al. (1998) Dihydropteridine reductase deficiency: physical structure of the QDPR gene, identification of two new mutations and genotype-phenotype correlations. Hum Mutat 12, 267273.
  • 97
    Ichinose H, Ohye T, Segawa M, Nomura Y, Endo K, Tanaka H, Tsuji S, Fujita K & Nagatsu T (1995) GTP cyclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation. Neurosci Lett 196, 58.
  • 98
    Toydemir RM, Brassington AE, Bayrak-Toydemir P, Krakowiak PA, Jorde LB, Whitby FG, Longo N, Viskochil DH, Carey JC & Bamshad MJ (2006) A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome. Am J Hum Genet 79, 935941.
  • 99
    Wiseman A (2004) Gene therapy for the circumvention of inborn errors of metabolism (IEM) caused by single-nucleotide-polymorphisms (SNPs). Med Hypotheses 63, 810812.
  • 100
    Tsai SJ, Hong CJ, Yeh HL, Liou YJ, Yang AC, Liu ME & Hwang JP (2011) Heterozygote advantage of the MTHFR C677T polymorphism on specific cognitive performance in elderly Chinese males without dementia. Dement Geriatr Cogn Disord 32, 159163.
  • 101
    Koonin EV & Novozhilov AS (2009) Origin and evolution of the genetic code: the universal enigma. IUBMB Life 61, 99111.
  • 102
    Perez JC (2010) Codon populations in single-stranded whole human genome DNA Are fractal and fine-tuned by the Golden Ratio 1.618. Interdiscip Sci 2, 228240.
  • 103
    Wu D, Yu W, Kishikawa H, Folkerth RD, Iafrate AJ, Shen Y, Xin W, Sims K & Hu GF (2007) Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol 62, 609617.
  • 104
    Spentchian M, Merrien Y, Herasse M, Dobbie Z, Glaser D, Holder SE, Ivarsson SA, Kostiner D, Mansour S, Norman A et al. (2003) Severe hypophosphatasia: characterization of fifteen novel mutations in the ALPL gene. Hum Mutat 22, 105106.
  • 105
    Wellcome Trust Sanger Institute GRL (2006) NCI-60 Cancer Cell Line Mutation Data. Cancer Genome Project, Cambridge, UK.
  • 106
    Tanabe M & Kanehisa M (2012) Using the KEGG database resource. Curr Protoc Bioinformatics 1, Unit 1.12.
  • 107
    Mi H, Guo N, Kejariwal A & Thomas PD (2007) PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res 35, D247252.
  • 108
    Mi H & Thomas P (2009) PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Methods Mol Biol 563, 123140.